ASMB — ASSEMBLY BIOSCIENCES, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1426800 ·
Last close
$35.28
Market Cap
$718.32M
52W High
$36.12
52W Low
$21.80
ADV30
215,542
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 8,213,000 | — | -11,370,000 | -9,079,000 | 235,508,000 | 31,120,000 | 36,898,000 |
| Dec 2025 | 42,469,000 | — | 19,799,000 | 22,090,000 | 257,590,000 | 58,450,000 | 50,839,000 |
| Sep 2025 | 10,789,000 | — | -10,883,000 | -9,196,000 | 239,997,000 | 22,534,000 | 57,302,000 |
| Jun 2025 | 9,626,000 | — | -11,093,000 | -10,198,000 | 80,780,000 | 24,006,000 | 62,680,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-39,751,000
Investing CF
$-125,436,000
Financing CF
$172,894,000
CapEx
$-43,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.76
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-841,126,000
Inventory
—
Receivables
$451,000
ST Investments
$195,481,000
EBIT TTM
$-13,547,000
Pretax Income TTM
$-6,383,000
Interest Exp TTM
—
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$74,845,000
EBITDA
$-8,688,000
Free Cash Flow
$-27,865,750
Enterprise Value
$400,310,816
Total Cash
$320,360,992
Total Debt
$2,350,000
Shares Out
20,360,596
Trailing EPS
$1.24
Book Value
$15.40
ROE
-0.0%
ROA
-2.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 72,303,000 | -12,118,000 | -6,122,000 | 257,590,000 | 50,839,000 | — | -41,093,000 |
| Dec 2024 | 28,520,000 | -45,420,000 | -40,177,000 | 119,168,000 | 85,809,000 | — | -51,117,000 |
| Dec 2023 | 7,163,000 | -64,646,000 | -61,228,000 | 136,823,000 | 95,726,000 | — | 22,743,000 |
| Dec 2022 | 0 | -94,114,000 | -93,092,000 | 101,794,000 | 19,130,000 | — | -84,463,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.89
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $20.00 · spot: $36.51 · call volume: 65 · put volume: 3Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | $716.89M | $3.29 | — |
| OCS | Oculis Holding AG | $731.86M | $13.18 | — |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $732.79M | $9.14 | — |
| PHAT | Phathom Pharmaceuticals, Inc. | $700.60M | $8.66 | — |
| PAHC | PHIBRO ANIMAL HEALTH CORP | $743.94M | $35.31 | — |
News headlines (Yahoo Finance, 1h cache)
Are You Looking for a Top Momentum Pick? Why Assembly Biosciences (ASMB) is a Great Choice
2026-08-20 16:00 · Yahoo
Wall Street Analysts Think Assembly Biosciences (ASMB) Could Surge 40.66%: Read This Before Placing a Bet
2026-08-20 13:55 · Yahoo
Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates
2026-08-13 20:00 · Yahoo
Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead
2026-06-08 17:03 · Yahoo
Assembly Biosciences Announces Upcoming Investor Conference Presentations
2026-05-28 20:05 · Yahoo
Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
2026-05-26 20:05 · Yahoo
Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants
2026-05-22 11:05 · Yahoo
These Analysts Just Made A Huge Downgrade To Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Forecasts
2026-05-13 11:29 · Yahoo
Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference
2026-05-11 12:00 · Yahoo
We're Hopeful That Assembly Biosciences (NASDAQ:ASMB) Will Use Its Cash Wisely
2026-05-11 11:12 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.